MedTrace Logo

Avastin for CNV Secondary to Pattern Dystrophy

NCT00391144 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2006-10-23

No results posted yet for this study

Summary

The natural history of subfoveal CNV secondary to Pattern Dystrophy is little understood, but it seems that visual function may be preserved only in the short-term follow-up, with progressive deterioration thereafter.

Photodynamic therapy with verteporfin is the most studied therapeuthic option for this kindf of lesion, but unfortunately, this approach does not appear to guarantee long-term vision stabilization, and alternative therapies should be investigated.

Conditions

  • Choroidal Neovascularization Secondary to Pattern Dystrophy

Interventions

PROCEDURE

intravitreal triamcinolone injection of avastin (1.25 mg)

Sponsors & Collaborators

  • University of Trieste

    lead OTHER

Principal Investigators

  • Maurizio B Parodi, MD · Clinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste

  • Pierluigi Iacono, MD · Clinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste

  • Giuseppe Ravalico, MD · Clinica Oculistica, Azienda Ospedaliero-Universitaria di Trieste

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Completion
2006-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00391144 on ClinicalTrials.gov